IBM has launched a study on the human microbiome and its role in disease

How the bugs in our gut and everywhere on our body affect our general health still remains largely a mystery. But IBM is hoping to shed some light onto the human microbiome and its role in autoimmune disorders employing crowdsourced supercomputers through its World Community Grid.

IBM has partnered up with the Broad Institute of Harvard and MIT, Massachusetts General Hospital, University of California San Diego, and the Simons Foundation’s Flatiron Institute for the study, which aims to map three million bacterial genes within human guts.

The hope is that this research will help scientists better understand how these bacteria lead to diseases like Type 1 diabetes, Hashimoto’rsquo, Crohn & thereforecolitis.

IBM isn&rsquo the only one appearing at our gut health. Actually, it appears to be en vogue for technology companies. Back in April, Alphabet’s life sciences arm Verily launched a job to encode data on the microbiome through the gut and DNA samples of 10,000 participants. Tech billionaire Naveen Jain began his own exploration of the subject with the development of Viome in 2016 and there have been several startups devoting up VC dollars to study the subject in the last few years.

IBM’s study will utilize the harness the computing power that is bulk in addition to the scientists in the aforementioned universities from volunteers across the globe. It is going to analyze findings and make them publicly available.

Read more: https://techcrunch.com

Most Popular

To Top